registHER: A prospective, longitudinal cohort study of women with HER2 positive metastatic breast cancer.

被引：0
|
作者：
Tanchiu, E
Kaufman, PA
Paik, S
Ulcickas-Yood, M
Mayer, M
Tripathy, D
Rugo, H
Brufsky, A
机构：
[1] Canc Res Network, Plantation, FL USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] NSABP, Pittsburgh, PA USA
[4] Episource LLC, Hamden, CT USA
[5] Patient Advocate, New York, NY USA
[6] Univ Texas, SW Med Ctr, Dallas, TX 75230 USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
[8] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46S / 46S
页数：1
相关论文
共 50 条
  • [21] Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real world study
    Feng, Jifeng
    Zhang, Lili
    Guo, Zhaoji
    Zhou, Jun
    Zhu, Mingzhen
    Wu, Xiaohong
    Yi, Tongbo
    Guo, Yujiang
    Li, Xiaoqin
    Yu, Hao
    Mao, Weidong
    Gu, Bei
    Han, Zhengxiang
    Zuo, Yun
    Liu, Yanhua
    Wang, Xufen
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [22] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Amar, Surabhi
    Moreno-Aspitia, Alvaro
    Perez, Edith A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 1 - 7
  • [23] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Surabhi Amar
    Alvaro Moreno-Aspitia
    Edith A. Perez
    [J]. Breast Cancer Research and Treatment, 2008, 109 : 1 - 7
  • [24] Outcome of non-metastatic HER2 positive breast cancer
    Mehmood, T.
    Rashid, A.
    Irfan, N.
    Hameed, S.
    Shah, M. Ali
    Jamshed, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S54 - S54
  • [25] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [26] Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER
    D A Yardley
    D Tripathy
    A M Brufsky
    H S Rugo
    P A Kaufman
    M Mayer
    J Magidson
    B Yoo
    C Quah
    M Ulcickas Yood
    [J]. British Journal of Cancer, 2014, 110 : 2756 - 2764
  • [27] Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER
    Yardley, D. A.
    Tripathy, D.
    Brufsky, A. M.
    Rugo, H. S.
    Kaufman, P. A.
    Mayer, M.
    Magidson, J.
    Yoo, B.
    Quah, C.
    Yood, M. Ulcickas
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2756 - 2764
  • [28] Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study
    Peter A. Kaufman
    Adam M. Brufsky
    Musa Mayer
    Hope S. Rugo
    Debu Tripathy
    Marianne Ulcickas Yood
    Shibao Feng
    Lisa I. Wang
    Cheng S. Quah
    Denise A. Yardley
    [J]. Breast Cancer Research and Treatment, 2012, 135 : 875 - 883
  • [29] Disparities in HER2 testing in breast cancer.
    Paryani, Vijay
    Schroeder, Mary Chen
    Klepin, Heidi D.
    Melin, Susan Anitra
    Russell, Greg B.
    Winkfield, Karen Marie
    Thomas, Alexandra
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] LAPATINIB IN HER2 POSITIVE METASTATIC CARCINOMA BREAST
    Behera, M. K.
    Sharma, A.
    Shukla, P.
    Julka, P. K.
    Rath, G. K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 50 - 50
12345